4//SEC Filing
ECLIPSYS CORP 4
Accession 0001209191-10-044025
CIK 0001034088operating
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 2:34 PM ET
Size
34.9 KB
Accession
0001209191-10-044025
Insider Transaction Report
Form 4
ECLIPSYS CORPECLP
GOMEZ JOHN
Exec. Vice President
Transactions
- Disposition to Issuer
Stock Option
2010-08-24−137,635→ 0 totalExercise: $19.70→ Common Stock (137,635 underlying) - Disposition to Issuer
Stock Option
2010-08-24−29,541→ 0 totalExercise: $13.26→ Common Stock (29,541 underlying) - Disposition to Issuer
Stock Option
2010-08-24−116,000→ 0 totalExercise: $13.35→ Common Stock (116,000 underlying) - Disposition to Issuer
Stock Option
2010-08-24−2,365→ 0 totalExercise: $19.70→ Common Stock (2,365 underlying) - Disposition to Issuer
Stock Option
2010-08-24−45,000→ 0 totalExercise: $7.97→ Common Stock (45,000 underlying) - Disposition to Issuer
Stock Option
2010-08-24−9,059→ 0 totalExercise: $11.95→ Common Stock (9,059 underlying) - Disposition to Issuer
Stock Option
2010-08-24−35,000→ 0 totalExercise: $22.07→ Common Stock (35,000 underlying) - Disposition to Issuer
Stock Option
2010-08-24−459→ 0 totalExercise: $13.26→ Common Stock (459 underlying) - Disposition to Issuer
Stock Option
2010-08-24−4,000→ 0 totalExercise: $13.35→ Common Stock (4,000 underlying) - Disposition to Issuer
Stock Option
2010-08-24−60,000→ 0 totalExercise: $7.97→ Common Stock (60,000 underlying) - Disposition to Issuer
Performance Stock Units
2010-08-24−50,000→ 0 totalExercise: $0.00→ Common Stock (50,000 underlying) - Disposition to Issuer
Common Stock
2010-08-24−63,750→ 0 total - Disposition to Issuer
Stock Option
2010-08-24−40,941→ 0 totalExercise: $11.95→ Common Stock (40,941 underlying)
Footnotes (6)
- [F1]As the transaction was fully described in the joint proxy statement dated July 14, 2010, as filed with the SEC, each Issuer share was converted into 1.2 shares of common stock of Allscripts Healthcare Solutions, Inc. pursuant to a merger of Issuer with a wholly-owned subsidiary of Allscripts. Shares that were converted included 6,250 shares of Issuer unvested restricted stock that will be subject to the same terms as specified in the original grant. Disposition by Reporting Person was approved by Issuer board of directors.
- [F2]In connection with the merger described above, each Issuer option was converted into an option to purchase Allscript common stock equal to 1.2 times the number of Issuer shares subject of the Issuer option and the exercise price was adjusted by dividing the Issuer exercise price by the 1.2 ratio in accordance with the merger agreement. Expiration date remains as originally set. This option was fully vested. Disposition by Reporting Person was approved by Issuer board of directors.
- [F3]In connection with the merger described above, each Issuer option was converted into an option to purchase Allscript common stock equal to 1.2 times the number of Issuer shares subject of the Issuer option and the exercise price was adjusted by dividing the Issuer exercise price by the 1.2 ratio in accordance with the merger agreement. Expiration date remains as originally set. Reporting Person's options were vested as to 21,146 Issuer shares. Vesting of the option with respect to the balance of shares will be as specified in the option documents. Disposition by Reporting Person was approved by Issuer board of directors.
- [F4]In connection with the merger described above, each Issuer option was converted into an option to purchase Allscript common stock equal to 1.2 times the number of Issuer shares subject of the Issuer option and the exercise price was adjusted by dividing the Issuer exercise price by the 1.2 ratio in accordance with the merger agreement. Expiration date remains as originally set. Reporting Person's options were vested as to 15,938 Issuer shares. Vesting of the option with respect to the balance of shares will be as specified in the option documents. Disposition by Reporting Person was approved by Issuer board of directors.
- [F5]In connection with the merger described above, each Issuer option was converted into an option to purchase Allscript common stock equal to 1.2 times the number of Issuer shares subject of the Issuer option and the exercise price was adjusted by dividing the Issuer exercise price by the 1.2 ratio in accordance with the merger agreement. Expiration date remains as originally set. Reporting Person's options were vested as to 21,250 Issuer shares. Vesting of the option with respect to the balance of shares will be as specified in the option documents. Disposition by Reporting Person was approved by Issuer board of directors.
- [F6]Each Performance Stock Unit ("PSU") represented a contingent right to receive a number of shares of Issuer's common stock ranging from 0 to 2.25, depending on the Issuer's Total Shareholder Return ("TSR") compared to the TSRs of a group of pre-selected companies in the healthcare technology and software industries over a performance period commencing on March 15, 2010 and ending on August 24, 2010, the effective date of the merger described above. As a result of the merger, each of the PSU's was converted into 1.2 shares of Allscripts common stock. Disposition by the Reporting Person was approved by Issuer's board of directors.
Documents
Issuer
ECLIPSYS CORP
CIK 0001034088
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001034088
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 2:34 PM ET
- Size
- 34.9 KB